SCHEMBL10359312

SCHEMBL10359312

CC[C@]1(CC(=O)O)CCC(=O)[C@H]2O[C@H]21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10359420 1.00 — —
SCHEMBL10359299 0.78 TSHR (0.33) —
SCHEMBL25290831 0.72 PRKCA (0.37) —
SCHEMBL10359555 0.70 IMPDH1 (0.36) —
SCHEMBL10359236 0.70 IMPDH1 (0.36) —
SCHEMBL10359313 0.68 PTGS1 (0.34) —
SCHEMBL17453508 0.65 CYP3A4 (0.31) —
SCHEMBL14291719 0.65 CYP3A4 (0.31) —
SCHEMBL3245958 0.65 PRKCA (0.36) —
SCHEMBL13075610 0.63 CYP1A2 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0213547-B1 CYCLOHEXANEALKANOIC ACIDS MERRELL DOW PHARMACEUTICALS INC. (US) 1990-12-27 — — EP claimed
Send feedback